BusinessBeOne Raises 2026 Outlook as Third-Quarter Revenue Climbs 34%By Helena WardNov 5, 2026, 8:38 PM UTC
HealthBeOne's BGB-B2033 Records a 36% Response Rate in Phase 1 Liver Cancer StudyBy Naomi CalderOct 24, 2026, 5:51 PM UTC